Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD

Didon L., Roos A. B., Elmberger G. P., Gonzalez F. J., Nord M.

Source: Eur Respir J 2010; 35: 186-197
Journal Issue: January
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Didon L., Roos A. B., Elmberger G. P., Gonzalez F. J., Nord M.. Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD. Eur Respir J 2010; 35: 186-197

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
RhoA signalling influences cyclin D1 expression and associated fibroblast turnover: implications for idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006


The relationship of the transcription factors AP-1 and NF-KB with lung function in the lungs of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001

Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population
Source: Eur Respir J 2001; 18: 482-490
Year: 2001



Differential CCAAT/enhancer binding protein (C/EBP) isoforms expression in human bronchial smooth muscle cells of asthmatic and COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 695s
Year: 2004

Unfolding the mechanisms of progression of pulmonary emphysema in COPD},
Source: Eur Respir J 2012; 40: 801-803
Year: 2012


High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis
Source: Annual Congress 2005 - Progresses in lung fibrosis
Year: 2005


Common pathways in idiopathic pulmonary fibrosis and cancer},
Source: Eur Respir Rev 2013; 22: 265-272
Year: 2013



Identification and quantification of NF-kB transcription factor in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001

Altered expression of the Smad signalling pathway: implications for COPD pathogenesis
Source: Eur Respir J 2006; 28: 533-541
Year: 2006



Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011

Variability of sputum inflammatory mediators in COPD and ?1-antitrypsin deficiency},
Source: Eur Respir J 2012; 40: 561-569
Year: 2012



Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 52S-63S
Year: 2003



Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015


Expression profile of Th1/Th2 transcription factors T-bet and GATA-3 in sarcoidosis, idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001

Elastin expression in very severe human COPD
Source: Eur Respir J 2009; 33: 324-331
Year: 2009



The role of infection in the pathogenesis of idiopathic pulmonary fibrosis},
Source: Eur Respir Rev 2013; 22: 376-381
Year: 2013



Evaluation of plasma LL-37 and nuclear factor kappa B (NF-?B) levels in stable chronic obstructive pulmonary disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017


The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020




Down-regulation of inhibitory of growth family member 4(ING4) in idiopathic pulmonary fibrosis (IPF). Correlation with disease progression
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009